Rational Therapeutics Based on Matched Tumor and Normal Tissue

计划入组 3 人 · 首次发布于 2014 年 10 月 23 日

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

计划入组 20 人 · 首次发布于 2020 年 7 月 22 日

A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies

计划入组 303 人 · 首次发布于 2013 年 5 月 17 日

Live attenuated HSV vaccine(Rational Vaccines, Inc.)

Antituberculosis therapeutics(AN2 Therapeutics, Inc.)

GTPase therapeutics (Perturba Therapeutics Inc.)

Rational Vaccines, Inc.

United States

JASPER THERAPEUTICS, INC

United States

CYTORI THERAPEUTICS, INC.

United States

Novel Metabolic Signatures Show Promise for Earlier Pancreatic Cancer Detection and Prognosis

Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies

Structure of the Argonaute Maturation Complex Guides Rational RNA Therapeutic Design